PortfoliosLab logoPortfoliosLab logo
VERA vs. VTSAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VERA vs. VTSAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vera Therapeutics, Inc. (VERA) and Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VERA achieves a -38.25% return, which is significantly lower than VTSAX's 11.98% return.


VERA

1D
0.03%
1M
-11.94%
YTD
-38.25%
6M
-24.21%
1Y
1.16%
3Y*
49.76%
5Y*
16.28%
10Y*

VTSAX

1D
0.24%
1M
5.76%
YTD
11.98%
6M
11.87%
1Y
29.09%
3Y*
22.34%
5Y*
13.04%
10Y*
15.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VERA vs. VTSAX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
VERA
Vera Therapeutics, Inc.
-38.25%19.74%174.97%-20.52%-27.58%132.35%
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
11.98%17.12%23.23%26.51%-19.52%13.18%

Correlation

The correlation between VERA and VTSAX is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since May 17, 2021

0.29

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VERA vs. VTSAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERA
VERA Risk / Return Rank: 4141
Overall Rank
VERA Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
VERA Sortino Ratio Rank: 4141
Sortino Ratio Rank
VERA Omega Ratio Rank: 4141
Omega Ratio Rank
VERA Calmar Ratio Rank: 4141
Calmar Ratio Rank
VERA Martin Ratio Rank: 4141
Martin Ratio Rank

VTSAX
VTSAX Risk / Return Rank: 7171
Overall Rank
VTSAX Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
VTSAX Sortino Ratio Rank: 6565
Sortino Ratio Rank
VTSAX Omega Ratio Rank: 6363
Omega Ratio Rank
VTSAX Calmar Ratio Rank: 7474
Calmar Ratio Rank
VTSAX Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VERA vs. VTSAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VERAVTSAXDifference

Sharpe ratio

Return per unit of total volatility

0.02

2.47

-2.45

Sortino ratio

Return per unit of downside risk

0.49

3.36

-2.87

Omega ratio

Gain probability vs. loss probability

1.06

1.44

-0.38

Calmar ratio

Return relative to maximum drawdown

0.03

3.37

-3.35

Martin ratio

Return relative to average drawdown

0.05

15.56

-15.52

VERA vs. VTSAX - Sharpe Ratio Comparison

The current VERA Sharpe Ratio is 0.02, which is lower than the VTSAX Sharpe Ratio of 2.47. The chart below compares the historical Sharpe Ratios of VERA and VTSAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VERAVTSAXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.02

2.47

-2.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.18

0.76

-0.57

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.82

Sharpe Ratio (All Time)

Calculated using the full available price history

0.24

0.47

-0.23

Drawdowns

VERA vs. VTSAX - Drawdown Comparison

The maximum VERA drawdown since its inception was -84.89%, which is greater than VTSAX's maximum drawdown of -55.33%. Use the drawdown chart below to compare losses from any high point for VERA and VTSAX.


Loading charts...

Drawdown Indicators


VERAVTSAXDifference

Max Drawdown

Largest peak-to-trough decline

-84.89%

-55.33%

-29.56%

Max Drawdown (1Y)

Largest decline over 1 year

-43.85%

-8.92%

-34.93%

Max Drawdown (3Y)

Largest decline over 3 years

-62.09%

-19.36%

-42.73%

Max Drawdown (5Y)

Largest decline over 5 years

-84.89%

-25.36%

-59.53%

Max Drawdown (10Y)

Largest decline over 10 years

-34.97%

Current Drawdown

Current decline from peak

-43.83%

0.00%

-43.83%

Average Drawdown

Average peak-to-trough decline

-40.02%

-9.01%

-31.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.61%

1.93%

+22.68%

Volatility

VERA vs. VTSAX - Volatility Comparison

Vera Therapeutics, Inc. (VERA) has a higher volatility of 18.47% compared to Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX) at 2.95%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than VTSAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VERAVTSAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.47%

2.95%

+15.52%

Volatility (6M)

Calculated over the trailing 6-month period

39.74%

9.19%

+30.55%

Volatility (1Y)

Calculated over the trailing 1-year period

62.83%

12.19%

+50.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

90.30%

17.36%

+72.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

91.49%

18.41%

+73.08%

Dividends

VERA vs. VTSAX - Dividend Comparison

VERA has not paid dividends to shareholders, while VTSAX's dividend yield for the trailing twelve months is around 1.00%.


PositionTTM20252024202320222021202020192018201720162015
VERA
Vera Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
1.00%1.11%1.26%1.42%1.65%1.20%1.41%1.76%2.03%1.71%1.92%1.98%

Frequently Asked Questions


VERA and VTSAX have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VERA has higher volatility (18.47%) compared to VTSAX (2.95%). In terms of maximum drawdown, VERA dropped -84.89% vs VTSAX's -55.33%.

VTSAX currently has the higher Sharpe Ratio (2.47 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VERA and VTSAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer